Skip to main content

Table 3 Cognitive and Psychological Assessments and Acetylcholinesterase Activity

From: Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease

 

Baseline

12 weeks

p-value (12 weeks vs. baseline)

MMSE

19.62 ± 4.71

20.29 ± 4.66

0.001*

FAST

4.24 ± 0.83

4.14 ± 0.85

0.16

ADCS-ADL

63.14 ± 8.6

63.29 ± 8.17

0.48

GDS

2.76 ± 1.09

2.86 ± 1.11

0.16

AChE activity (IU/L)

276.81 ± 56.28

159.81 ± 60.25

< 0.001*

  1. Paired sample t-test: *p < 0.05
  2. AChE Acetylcholinesterase, ADCS-ADL Alzheimer’s Disease Cooperative Study Activities of Daily Living, FAST Functional Assessment Staging, GDS Geriatric Depression Scale, MMSE Mini-Mental State Examination
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us